MDLN Medline Inc.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Medline (NASDAQ: MDLN)
›
Medline (NASDAQ: MDLN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 45,000 employees.
The shares were at 37.84 USD on 19 November 2026. Its 52-week range is 31.37 USD to 50.88 USD: the price is 25.6% below the high and 20.6% above the low.
At a market capitalisation of 49.80B USD, it trades at 86.0 times trailing earnings and 24.5 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 48.1, a premium of 79% for MDLN.
Medline reports return on equity of 10.8%, an operating margin of 5.4% and revenue up 10.4% year over year.
Its debt exceeds its cash by 9.03B USD, a debt-to-equity ratio of 1.18. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 23 analysts cover the stock, with an average rating of Buy; their mean price target of 45.61 USD is 20.5% above the current price. The next earnings report is expected on 24 February 2027.